0001250853-13-000002.txt : 20130107
0001250853-13-000002.hdr.sgml : 20130107
20130107173329
ACCESSION NUMBER: 0001250853-13-000002
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20130107
DATE AS OF CHANGE: 20130107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVITT DANIEL J
CENTRAL INDEX KEY: 0001278711
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15327
FILM NUMBER: 13516147
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORP
STREET 2: 2929 SEVENTH ST STE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTRX CORP
CENTRAL INDEX KEY: 0000799698
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581642750
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
BUSINESS PHONE: 310-826-5648
MAIL ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4/A
2012-12-31
2013-01-02
0
0000799698
CYTRX CORP
CYTR
0001278711
LEVITT DANIEL J
11726 SAN VICENTE BLVD., SUITE 650
LOS ANGELES
CA
90049
0
1
0
0
EVP & Chief Medical Officer
Common Stock
2012-12-31
4
A
0
100000
0
A
114286
D
Reflects reduction in shares owned due to 1-for-7 reverse stock split of the Issuer's common stock in May 2012.
/s/ Daniel J. Levitt
2013-01-05